Diabetes Education News

Semaglutide conferred greater reductions in HbA1c and body weight among adults with type 2 diabetes than other GLP-1 receptor agonists, according to findings from a systematic review and meta-analysis.

A new generation of obesity drugs is changing the treatment landscape for patients and providers, with options that can lead to weight loss unheard of just a few years ago.

Diabetes has emerged as a worldwide health crisis, affecting a diverse set of demographically distinct patients with varying levels of severity. Balancing norms and evidence-based practices with sensitivity is key to culturally competent diabetes care.

Last month, WHO’s International Agency for Research on Cancer declared aspartame — a popular artificial sweetener that is used in products like soft drinks, chewing gum and ice cream — a potential carcinogen.

A 10-year intensive lifestyle intervention designed for weight loss in those with type 2 diabetes and overweight/obesity was tied to significantly higher employment levels compared with diabetes education alone, according to researchers.

Adults with diabetes who smoke or exercise less than once per week are among those at higher risk for a lower limb amputation, but adults with obesity may have a lower risk for amputations, according to study data.

HOUSTON — SGLT2 inhibitors should be the first choice of therapy for adults with type 2 diabetes and heart failure, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.

Amazon Pharmacy is launching new technology that will automatically apply manufacturer coupons for customers purchasing insulin and diabetes care products, according to a press release.

HOUSTON — People with type 1 diabetes who use cannabis and present at a hospital with diabetic ketoacidosis symptoms may have hyperglycemic ketosis related to cannabis hyperemesis syndrome, according to a speaker.

Healio spoke with David Klonoff, MD, about unmet needs in the field of diabetes technology.